Panu K. Luukkonen

4.5k total citations · 4 hit papers
45 papers, 2.3k citations indexed

About

Panu K. Luukkonen is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Panu K. Luukkonen has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 20 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Hepatology. Recurrent topics in Panu K. Luukkonen's work include Liver Disease Diagnosis and Treatment (36 papers), Diet, Metabolism, and Disease (19 papers) and Lipid metabolism and biosynthesis (7 papers). Panu K. Luukkonen is often cited by papers focused on Liver Disease Diagnosis and Treatment (36 papers), Diet, Metabolism, and Disease (19 papers) and Lipid metabolism and biosynthesis (7 papers). Panu K. Luukkonen collaborates with scholars based in Finland, United States and Sweden. Panu K. Luukkonen's co-authors include Hannele Yki‐Järvinen, Johanna Arola, Tuulia Hyötyläinen, Matej Orešič, Leanne Hodson, You Zhou, Sanja Sädevirta, Anne Salonen, Ching Jian and Marja Leivonen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Panu K. Luukkonen

41 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

2016 335 citations Panu K. Luukkonen, You Zhou et al. Journal of Hepatology profile →
Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling

2020 246 citations Ching Jian, Panu K. Luukkonen et al. PLoS ONE profile →
Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease

2021 204 citations S. U. Qadri, Panu K. Luukkonen et al. Journal of Hepatology profile →
Dietary carbohydrates and fats in nonalcoholic fatty liver disease

2021 183 citations Hannele Yki‐Järvinen, Panu K. Luukkonen et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers

Countries citing papers authored by Panu K. Luukkonen

Since Specialization

Citations

This map shows the geographic impact of Panu K. Luukkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panu K. Luukkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panu K. Luukkonen more than expected).

Fields of papers citing papers by Panu K. Luukkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panu K. Luukkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panu K. Luukkonen. The network helps show where Panu K. Luukkonen may publish in the future.

Co-authorship network of co-authors of Panu K. Luukkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Panu K. Luukkonen. A scholar is included among the top collaborators of Panu K. Luukkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panu K. Luukkonen. Panu K. Luukkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of new CORE risk score to predict 10 year risk of liver cirrhosis in general population: population based cohort study 2025 ·BMJ ·(unknown), Fredrik Åberg, (unknown), Panu K. Luukkonen, Veikko Salomaa, Antti Jula, Annamari Lundqvist, Satu Männistö, (unknown), Mats Talbäck, Niklas Hammar, Hannes Hagström	1
2	Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans 2025 ·Liver International ·Hannele Yki‐Järvinen, Panu K. Luukkonen	2
3	Evidence-based criteria for identifying at-risk individuals requiring liver disease screening 2025 ·Hepatology Communications ·Fredrik Åberg, (unknown), (unknown), Veikko Salomaa, Antti Jula, Annamari Lundqvist, Satu Männistö, Markus Perola, Panu K. Luukkonen	0
4	Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease 2024 ·Trends in Pharmacological Sciences ·Mari J. Jokinen, Panu K. Luukkonen	9
5	Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis 2023 ·Science Translational Medicine ·Meghan Mooring, (unknown), Panu K. Luukkonen, Silvia Liu, (unknown), (unknown), (unknown), Xuemei Yu, (unknown), Kari Nejak‐Bowen, Masha V. Poyurovsky, Carmen J. Booth, Liza Konnikova, Gerald I. Shulman, Dean Yimlamai	14
6	Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis 2023 ·Proceedings of the National Academy of Sciences ·Panu K. Luukkonen, Ikki Sakuma, Rafael Calais Gaspar, Meghan Mooring, Ali Nasiri, Mario Kahn, Xian‐Man Zhang, Dongyan Zhang, Henna Sammalkorpi, Anne Penttilä, Marju Orho‐Melander, Johanna Arola, Anne Juuti, Xuchen Zhang, Dean Yimlamai, Hannele Yki‐Järvinen, Kitt Falk Petersen, Gerald I. Shulman	36
7	The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans 2023 ·Cell Metabolism ·Panu K. Luukkonen, Kimmo Porthan, (unknown), Fredrik Rosqvist, Sylvie Dufour, Xian‐Man Zhang, Tiina E. Lehtimäki, (unknown), Marju Orho‐Melander, Leanne Hodson, Kitt Falk Petersen, Gerald I. Shulman, Hannele Yki‐Järvinen	45
8	Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition 2023 ·Proceedings of the National Academy of Sciences ·Ikki Sakuma, Rafael Calais Gaspar, Panu K. Luukkonen, Mario Kahn, Dongyan Zhang, Xuchen Zhang, Sue Murray, Jaya Prakash Golla, Daniel F. Vatner, Varman T. Samuel, Kitt Falk Petersen, Gerald I. Shulman	10
9	Abdominal obesity and alcohol use modify the impact of genetic risk for incident advanced liver disease in the general population 2023 ·Liver International ·Panu K. Luukkonen, Martti Färkkilâ, Antti Jula, Veikko Salomaa, Satu Männistö, Annamari Lundqvist, Markus Perola, Fredrik Åberg	9
10	Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score 2022 ·Journal of Hepatology ·Fredrik Åberg, Panu K. Luukkonen, Anna But, Veikko Salomaa, Annie Britton, K. Petersen, Stig E. Bojesen, Mie Balling, Børge G. Nordestgaard, Pauli Puukka, Satu Männistö, Annamari Lundqvist, Markus Perola, Antti Jula, Martti Färkkilâ	36
11	Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease 2021 ·Journal of Hepatology ·Panu K. Luukkonen, S. U. Qadri, (unknown), Kimmo Porthan, Ville Männistö, Henna Sammalkorpi, Anne Penttilä, Antti Hakkarainen, Tiina E. Lehtimäki, Melania Gaggini, Amalia Gastaldelli, Mika Ala‐Korpela, Marju Orho‐Melander, Johanna Arola, Anne Juuti, Jussi Pihlajamäki, Leanne Hodson, Hannele Yki‐Järvinen	121
12	Dietary carbohydrates and fats in nonalcoholic fatty liver disease breakdown → 2021 ·Nature Reviews Gastroenterology & Hepatology ·Hannele Yki‐Järvinen, Panu K. Luukkonen, Leanne Hodson, J. Bernadette Moore	183
13	Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 2021 ·Gastroenterology ·Oveis Jamialahmadi, Rosellina Margherita Mancina, Ester Ciociola, Federica Tavaglione, Panu K. Luukkonen, Guido Baselli, Francesco Malvestiti, Dorothée Thuillier, Violeta Raverdy, Ville Männistö, Rosaria Maria Pipitone, Grazia Pennisi, Daniele Prati, Rocco Spagnuolo, Salvatore Petta, Jussi Pihlajamäki, François Pattou, Hannele Yki‐Järvinen, Luca Valenti, Stefano Romeo	85
14	The PNPLA3‐I148M variant increases polyunsaturated triglycerides in human adipose tissue 2020 ·Liver International ·S. U. Qadri, (unknown), Panu K. Luukkonen, You Zhou, Amalia Gastaldelli, Marju Orho‐Melander, Henna Sammalkorpi, Anne Juuti, Anne Penttilä, Julia Perttilä, Antti Hakkarainen, Tiina E. Lehtimäki, Matej Orešič, Tuulia Hyötyläinen, Leanne Hodson, Vesa M. Olkkonen, Hannele Yki‐Järvinen	18
15	The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Panu K. Luukkonen, S. U. Qadri, Tiina E. Lehtimäki, Anne Juuti, Henna Sammalkorpi, Anne Penttilä, Antti Hakkarainen, Marju Orho‐Melander, Johanna Arola, Hannele Yki‐Järvinen	22
16	Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease 2020 ·Proceedings of the National Academy of Sciences ·Panu K. Luukkonen, Sylvie Dufour, Kun Lyu, (unknown), Antti Hakkarainen, Tiina E. Lehtimäki, Gary W. Cline, Kitt Falk Petersen, Gerald I. Shulman, Hannele Yki‐Järvinen	178
17	LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 2020 ·Gut ·Yuki Tanaka, Yuta Shimanaka, Andrea Caddeo, Takuya Kubo, Yanli Mao, Tetsuya Kubota, Naoto Kubota, Toshimasa Yamauchi, Rosellina Margherita Mancina, Guido Baselli, Panu K. Luukkonen, Jussi Pihlajamäki, Hannele Yki‐Järvinen, Luca Valenti, Hiroyuki Arai, Stefano Romeo, Nozomu Kono	97
18	Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults 2020 ·Clinical Nutrition ·Ching Jian, Panu K. Luukkonen, Sanja Sädevirta, Hannele Yki‐Järvinen, Anne Salonen	40
19	Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling breakdown → 2020 ·PLoS ONE ·Ching Jian, Panu K. Luukkonen, Hannele Yki‐Järvinen, Anne Salonen, Katri Korpela	246
20	Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) – an 11-Year Prospective Study 2017 ·Scientific Reports ·Susanna Lallukka, Sanja Sädevirta, (unknown), Panu K. Luukkonen, You Zhou, Antti Hakkarainen, Nina Lundbom, Marju Orho‐Melander, Hannele Yki‐Järvinen	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact